Jiangsu Jibeier Pharmaceutical Co Ltd (688566) — Cash Flow-to-Debt Ratio
Jiangsu Jibeier Pharmaceutical Co Ltd (688566) has a Cash Flow-to-Debt Ratio of 0.04x as of September 2025, meaning its operating cash flow of CN¥11.07 Million could theoretically repay 0% of its total liabilities (CN¥269.87 Million) in one year. See free cash flow generation of Jiangsu Jibeier Pharmaceutical Co Ltd to measure how efficiently the company converts operating cash flow to free cash.
CF-to-Debt Ratio
Operating Cash Flow
Total Liabilities
Data as of
Jiangsu Jibeier Pharmaceutical Co Ltd Cash Flow-to-Debt Ratio (2016–2025)
Historical debt coverage capacity for Jiangsu Jibeier Pharmaceutical Co Ltd across 10 annual periods. Also explore Jiangsu Jibeier Pharmaceutical Co Ltd equity growth rate to track the company's year-over-year net asset growth rate.
Annual Cash Flow-to-Debt Ratio for Jiangsu Jibeier Pharmaceutical Co Ltd (2016–2025)
Year-by-year debt coverage analysis for Jiangsu Jibeier Pharmaceutical Co Ltd. For market capitalisation and broader financial context, see Jiangsu Jibeier Pharmaceutical Co Ltd market cap and net worth.
| Year | CF-to-Debt Ratio | Operating CF (CNY) | Total Liabilities | YoY Change |
|---|---|---|---|---|
| 2025 | 0.93x | CN¥248.30 Million | CN¥267.47 Million | ▲ +18.0% |
| 2024 | 0.79x | CN¥215.29 Million | CN¥273.68 Million | ▲ +47.6% |
| 2023 | 0.53x | CN¥159.50 Million | CN¥299.25 Million | ▼ -4.4% |
| 2022 | 0.56x | CN¥150.72 Million | CN¥270.24 Million | ▼ -22.1% |
| 2021 | 0.72x | CN¥150.56 Million | CN¥210.40 Million | ▲ +4.2% |
| 2020 | 0.69x | CN¥117.36 Million | CN¥170.92 Million | ▼ -25.6% |
| 2019 | 0.92x | CN¥115.45 Million | CN¥125.16 Million | ▲ +13.3% |
| 2018 | 0.81x | CN¥97.97 Million | CN¥120.32 Million | ▼ -36.6% |
| 2017 | 1.28x | CN¥111.66 Million | CN¥86.92 Million | ▲ +289.1% |
| 2016 | 0.33x | CN¥39.29 Million | CN¥118.99 Million | — |